Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese ...

Concord Biotech had its toughest year as a listed company, with revenue and profit falling sharply. But a closer look reveals ...

Ionis Pharmaceuticals' shares are down more than 27% so far this year. What does Cathie Wood see that others are missing?

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...

Biotech is commanding attention from dealmakers and investors. Pharma companies have acquired 37 biotech firms worth at least $1 billion this year, more than all of 2025, as they race to bolster ...

Cathie Wood of Ark Invest first bought shares of Beam Therapeutics (BEAM 4.14%), a biotech focused on precision genetic ...

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules ...

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

On paper, it was another strong quarter for Carvykti. Johnson & Johnson reported record sales for the CAR-T therapy, ...

Launching with three products, Re:You targets hair thinning and vitality using AI-driven Novogro technology.